EGFR and breast carcinoma: Pursuing our interest in n-10 fatty acids, here we present the results of SA supplementation in breast cancer cells, studied in terms of membrane FA incorporation and remodeling, and associating for the first time the oncogenic signaling cascade of EGFR, AKT (protein kinase B) and mTOR (mammalian target of rapamycin) [21].